Charles Albright, Chief Scientific Officer at Editas Medicine, Inc. (EDIT), sold 11,098 shares at $26.54 ($295K) on 2020-02-03, disclosed to the SEC on 2020-02-04.
Open-market sale of $295k EDIT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.54 | 5,549 | $147K | 50.0% |
| 2 | $26.54 | 5,549 | $147K | 50.0% |
| Total | $26.54 avg | 11,098 | $295K | 100% |
| Filing → |
| EDIT | SELL | 2020-12-08 | $1.6M | — | Filing → |
| EDIT | SELL | 2020-11-10 | $7K | — | Filing → |
| EDIT | SELL | 2020-10-16 | $94K | — | Filing → |